Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-24-128889·INTEGRATED CORE STRATEGIES (US) LLC
Schedule 13G ownership disclosure
PYXIS ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 747324101
Event date: 2024-12-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 3,133,292.00 · Class: 5.3%
- Millennium Management LLC
Shares: 3,160,139.00 · Class: 5.3%
- Millennium Group Management LLC
Shares: 3,160,139.00 · Class: 5.3%
- Israel A. Englander
Shares: 3,160,139.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-128889
- Form type
- SCHEDULE 13G
- Filer
- INTEGRATED CORE STRATEGIES (US) LLC
- CIK
- CIK 1319244
- Filed
- Dec 16, 2024
- Reporting period
- Dec 09, 2024
- Description
- Schedule 13G beneficial ownership